Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
4
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biogen
biotech
cancer immunotherapy
drug prices
eli lilly
gene therapy
johnson & johnson
abbvie
aduro biotech
What
bio
roundup
drug
alzheimer’s
companies
price
acquisitions
albert
approval
biggest
biogen’s
biopharmaceutical
bourla
ceo
company
congress
convo
crispr
democrats
different
divided
earlier
elections
fail
failures
fallout
future
gene
imports
increases
latest
littered
losses
maker
maps
measured
midterm
nash
new
news
Language
unknown
Current search:
medicare
×
startups
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel